Glen Eagle Advisors, LLC Schrodinger, Inc. Transaction History

Glen Eagle Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Aug 13, 2024	SELL	$33.38 - $59.25 $18,359 - $32,587	-550 Closed	0 $0
Q2 2021 Aug 13, 2024	BUY	$59.02 - $78.8 $2,065 - $2,758	35 Added 6.8%	550 $41.6 Million
Q4 2020 Aug 13, 2024	BUY	$48.06 - $84.4 $24,750 - $43,466	515 New	515 $40.8 Million
Q3 2020 Aug 13, 2024	BUY	$46.87 - $93.33 $11,811 - $23,519	252 Added 154.6%	415 $19.7 Million
Q2 2020 Aug 13, 2024	BUY	$36.12 - $91.57 $5,887 - $14,925	163 New	163 $14.9 Million

239

61.4M

726K

329K

Ticker SDGR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 62,028,400
Market Cap $1.53B
Description
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Glen Eagle Advisors, LLC with notifications on news.